IMPACCT_RWE Home page banner

Returning for its 7th year, IMPACCT: RWE provides top innovators and leaders in the real world evidence space with a comprehensive industry forum dedicated to supporting and advancing the generation and utilization of real world evidence across drug life cycle, from clinical development to commercialization.

Join your peers and leading experts for a collaborative open discussion aiming to tackle key challenges to accelerate the meaningful implementation of real world evidence approaches to enhance clinical R&D outcomes, drive patient-centricity, and maximize the success of launch and commercialization activities.

Frank Zhang

VP, Head of Market Access


Javier Jimenez

VP & Global Head of RWE & Clinical Outcomes


Melvin Olson

Global Head, RWD Strategy & Innovation


Tony Hebden


HEOR, AbbVie

Danny Wiederkehr

Senior Director, Global HEOR Team Lead


Judy Kando

VP, Head of Medical Affairs

Tris Pharma

Keith Friend

Global Medical Director, Cardiovascular

Bristol-Myers Squibb

Marla Curran

Executive Director, Head of Biometrics & Medical Writing

Paratek Pharmaceuticals

Proud To Partner With

Official Media Partners